A Better Way to Recruit, Engage, and Retain Patients in Clinical Research

Effectively connect and communicate throughout the patient journey to keep your patients enrolled and your clinical trials on track.

Get a Free Consult
Doctor talking with couple patients

Bridge the Language Gaps that Add Complexity to Patient Enrollment, Engagement, and Retention

TransPerfect provides the patient-centric services that support you in reaching patients, meeting enrollment numbers, and meeting diversity and inclusion goals. With extensive market research and global expertise, our local digital marketing experts develop strategic recruitment marketing plans and messaging that engage patients across all channels. 

Our Patient-Centric Tech Solutions and Services

    Trusted by Life Sciences Organizations Big and Small

    Join TransPerfect's community of over 1,000 life sciences organizations, including pharma, biotech, CROs, IRBs, and agencies.

    20230124-lifesciences-resize-v3_0015_400x160px-merck_logo.png
    20230124-lifesciences-resize-v3_0016_400x160px-bayer_logo.png
    20230124-lifesciences-resize-v3_0022_400x160px-hologic_logo.png
    20230124-lifesciences-resize-v3_0018_400x160px-johnsonandjohnson_logo.png

    Ready to Improve Your Patient Services?

    How did you hear about us?
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

    News and Press Releases

    Our industry experts have in-depth understanding of the challenges, requirements, and goals for life sciences organizations involved in clinical trial management.

    How Medical Communications Teams Can Scale Reviews Without Sacrificing Speed

    Medical communications teams are under mounting pressure to review more content than ever before without adding headcount or increasing risk. This white paper outlines five pillars for rethinking MLR workflows, from modular content and tiered reviews to automation and governance. Get a realistic roadmap to alleviate team burnout, scale reviews, remove bottlenecks, and stay compliant. ...

    How Medical Communications Teams Can Scale Reviews Without Sacrificing Speed

    From Draft to Deployment: Creating Global-Ready Content from the Start

    Clinical, regulatory, and commercial teams all rely on the same content, yet often work in siloes. This white paper examines the real cost of disconnected content strategies and why localization should be treated as a strategic input, not a final step. Discover how global-ready ...

    Operationalizing AI in Global Pharma Product Launch

    AI has moved from a sensitive topic to a standard expectation in pharmaceutical organizations. Leadership teams are asking for it. Departments are experimenting with it. Pilot programs are underway across the enterprise.Yet despite this momentum, most AI initiatives stall...

    Process AI in Medical Device: What Works and What’s Next

    The webinar will also explore the use of Process AI across life sciences operations. Instead of treating each process, such as post-market surveillance, complaint handling, systematic literature review and regulatory content authoring, like separate AI projects, this session will ...

    Localizing Health Apps at Global Scale: UI/UX Considerations

    With 200 new mHealth (mobile health) apps launching daily, it’s safe to say that the digital health market is exploding. For health-tech startups and established organizations looking to scale across global markets, the differentiator in a competitive landscape isn’t always...

    Back to the Basics: Foundations of COA Localization

    This blog is a follow-up from our webinar Foundations of Clinical Outcome Assessment Localization.Clinical outcome assessments (COAs) play an increasingly central role in capturing how patients feel, function, and experience their condition or treatment. Yet as studies...

    Integrating AI to Scale & Accelerate Workflows and Improve Pharma Product Launches

    Bringing a new medical product to market has always been a challenge, though advances in recent tools have promised a new age of streamlined processes and accelerated time to launch. However, most pharma commercial AI pilots never make it past proof of concept due to siloed ...